Managing IP is rounding up important intellectual property decisions coming out of Canadian courts last year. In two patent cases, the Court of Appeal suggested a new legal test for determining the relevance of a non-infringing alternative and ruled that a generic cannot make a claim for innovator profits under the doctrine of unfair enrichment
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application